Skip to main content
. 2024 Feb 21;6(2):280–297. doi: 10.1007/s42995-023-00215-9

Table 3.

Potential therapeutic drug targets against SARS-CoV-2

SARS-CoV-2 Host
Spike protein Proteases of host
Envelope protein Proprotein convertase (PPC)
Membrane protein Toll-like receptors (TLRs)
Nucleoprotein High-density lipoprotein (HDL) scavenger receptor B type 1 (SR-B1)
Replicase protein Glycosaminoglycans (GAGs) on the cell surface
Main protease (Mpro or 3CLpro)
Papine-like protease
RNA-dependent RNA polymerase
Non-structural proteins